Evidence map›Paper›PMID 28653505›Full record

ArticleInternational journal of cancer2017

Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.

Junya Fujimoto, Sayuri Nunomura-Nakamura, Yihua Liu, Wenhua Lang, Tina McDowell, Yasminka Jakubek, Dalia Ezzeddine, Joshua Kapere Ochieng, Jason Petersen, Gareth Davies and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Multi-omics characterization of a GPRC5AJournal of translational medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Therapeutic Interception of Early Lung Adenocarcinoma Progression: Not Just How, but When?American journal of respiratory and critical care medicine · 2021
    Article
  14. Article
  15. microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Junya FujimotoDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Sayuri Nunomura-NakamuraDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Yihua LiuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wenhua LangDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Tina McDowellDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Yasminka JakubekDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dalia EzzeddineDepartment of Chemistry, American University of Beirut, Beirut, Lebanon.
Joshua Kapere OchiengDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jason PetersenAvera Institute for Human Genetics, Sioux Falls, SD.
Gareth DaviesAvera Institute for Human Genetics, Sioux Falls, SD.
Junya FukuokaGraduate School of Biomedical Science, Nagasaki University, Nagasaki, Japan.
Ignacio I WistubaDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Erik EhliAvera Institute for Human Genetics, Sioux Falls, SD.
Jerry FowlerDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Paul ScheetDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Humam KadaraDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0003-2976-9115
The University of Texas MD Anderson Cancer Center · USAvera Health · USAmerican University of Beirut · LBNagasaki University · JP

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
(PQ1) Progression of the airway field of injury to Kras mutant lung cancerR01CA205608 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KADARA, HUMAM, SCHEET, PAUL A · 2016 to 2019
$1.4M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA205608
6 · The paper itself

Abstract

Despite the urgency for prevention and treatment of lung adenocarcinoma (LUAD), we still do not know drivers in pathogenesis of the disease. Earlier work revealed that mice with knockout of the G-protein coupled receptor Gprc5a develop late onset lung tumors including LUADs. Here, we sought to further probe the impact of Gprc5a expression on LUAD pathogenesis. We first surveyed GPRC5A expression in human tissues and found that GPRC5A was markedly elevated in human normal lung relative to other normal tissues and was consistently downregulated in LUADs. In sharp contrast to wild-type littermates, Gprc5a

Indexed as

AdenocarcinomaAdenocarcinoma of LungAnimalsCarcinogensCell LineageGenes, Tumor SuppressorHumansLung NeoplasmsMiceMice, KnockoutMutationNitrosaminesProto-Oncogene Proteins p21(ras)Receptors, G-Protein-Coupled4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneCarcinogensGPRC5A protein, humanGPRC5A protein, mouseHras protein, mouseKRAS protein, humanNitrosaminesProto-Oncogene Proteins p21(ras)Receptors, G-Protein-CoupledcarcinogenesisGprc5aKraslung adenocarcinomawhole-exome sequencing

Identifiers

PMID28653505
PMCPMC5774849
OpenAlexW2727364912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.